Abstract
The study of human cancers has been impaired by a lack of good animal models. Human cancers are difficult to grow in culture, and the use of immunologically deficient mice has had limited success in propagating human tumors [1]. If a tumor is able to grow in a mouse, its ability to subsequently survive in culture is enhanced. We and others have found much greater take and growth of both murine and human tumor cells and primary isolates in mice when the cells are premixed with a basement membrane extract (Matrigel) and injected subcutaneously [2–5]. In addition, we have been able to further increase the growth of solid tumors by the inclusion of a synthetic angiogenic peptide derived from the laminin A chain [6]. In contrast, anti-angiogenic peptides reduce the tumor growth even when intra-peritoneal injections of the peptide are initiated several days after tumor growth has begun [3]. Although these subcutaneous tumors do not frequently metastasize, the growth of such tumors is an important first step in developing animal models to study the metastatic and phenotypic properties of human cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Romijn JC, Verkoelen CF, Schroeder FH. 1986. Measurement of the survival of human tumors after implantation in athymic nude mice. Int J Cancer 38: 97–101.
Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. 1990. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA 87: 6698–6702.
Fridman R, Kibbey MC, Royce LS, Zain M, Sweeney TM, Jicha DL, Yannelli JR, Martin GR, Kleinman HK. 1991. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J Natl Cancer Inst 83: 679–774.
Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG, Pretlow TP. 1991. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 51: 3814–3817.
Passaniti A, Isaacs JT, Haney JA, Adler SH, Cujdik TJ, Long PV, Kleinman HK. 1992. Stimulation of human prostate carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int J Cancer 51: 318–324.
Kibbey MC, Grant DS, Kleinman HK. 1992. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst 84: 1633–1638.
Martin GR, Timpl R. 1987. Laminin and other basement membrane components. Annu Rev Cell Biol 3: 57–85.
Liotta LA, Rao CN, Wewer UM. 1986. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037–1057.
Terranova VP, Williams JE, Liotta LA, Martin GR. 1984. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 226: 982–985.
Kleinman HK, Graf J, Iwamoto Y, Kitten GT, Ogle RC, Sasaki M, Yamada Y, Martin GR, Luckenbill-Edds L. 1987. Role of basement membranes in cell differentiation. Ann NY Acad Sci 513: 134–145.
Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245.
Wewer UM, Liotta LA, Jaye M, Recia GA, Drohan WN, Claysmith AP, Rao CN, Wirth P, Coligan JE, Albrechtsen R, Mudryj M, Sobel M. 1986. Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci USA 83: 7137–7141.
Yow HK, Wong JM, Chen HS, Lee C, Steele GD Jr, Chen LB. 1988. Increased mRNA expression of a laminin binding protein in human colon carcinoma. Complete sequence of a full-length cDNA encoding the protein. Proc Natl Acad Sci USA 85: 6394–6398.
Tashiro K, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK, Yamada Y. 1989. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem 264: 16174–16182.
Kanemoto T, Reich R, Royce L, Greatorex D, Adler SH, Shiraishi N, Martin GR, Yamada Y, Kleinman HK. 1990. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc Natl Acad Sci USA 87: 2279–2283.
Sweeney TM, Kibbey MC, Zain M, Fridman R, Kleinman HK. 1991. Basement membrane and the laminin peptide containing SIKVAV promote tumor growth and metastases. Cancer Metastases Rev 10: 245–254.
Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y. 1987. Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis and receptor binding. Cell 48: 989–996.
Iwamoto Y, Graf J, Sasaki M, Kleinman HK, Martin GR, Robey FA, Yamada Y. 1988. A synthetic pentapeptide from the Bl chain of laminin is chemotactic for B16F10 melanoma cells. J Cell Physiol 134: 287–291.
Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR. 1987. YIGSR a pentapeptide from the Bl chain of laminin inhibits tumor cell metastases. Science 328: 1132–1134.
Sakamoto N, Iwahana M, Tanaka NG, Osada Y. 1991. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide CDPGYIGSR-NH2. Cancer Res 51: 903–906.
Saiki I, Murata J, Iida J, Nishi J, Sugimura K, Azuma I. 1989. Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesion arg-gly-asp (RGD) and tyr-ile-gly-ser-arg (YIGSR) sequences. Br J Cancer 59: 194–197.
Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR. 1986. Basement membrane complexes with biological activity. Biochemistry 25: 312–318.
Jun SH, Thompson EW, Gottardis M, Torri J, Yamamura K, Kibbey MC, Kim WH, Kleinman HK. 1994. Laminin adhesion-selected primary human colon cancer cells are more tumorigenic than the parental and nonadherent cells. Int J One 4: 55–60.
Grant DS, Kinsella JL, Fridman R, Auerbach R, Piasecki BA, Yamada Y, Zain M, Kleinman HK. 1992. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 153: 614–625.
Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. 1989. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures. Cell 58: 933–943.
Liotta LA, Steeg PS, Stetler-Stevenson WG. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kibbey, M.C., Yamamura, K., Jun, S.H., Grant, D.S., Kleinman, H.K. (1994). Enhancement of tumor growth by basement membrane: Modulation of growth and angiogenesis by laminin-derived synthetic peptides. In: Dickson, R.B., Lippman, M.E. (eds) Mammary Tumorigenesis and Malignant Progression. Cancer Treatment and Research, vol 71. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2592-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2592-9_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6109-1
Online ISBN: 978-1-4615-2592-9
eBook Packages: Springer Book Archive